Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q3 2025 Earnings Call Transcript November 4, 2025
Taysha Gene Therapies, Inc. misses on earnings expectations. Reported EPS is $-0.09265 EPS, expectations were $-0.09.
Operator: Good day, everyone and welcome to The Taysha Gene Therapies Third Quarter 2025 Earnings Call. [Operator Instructions] Please note, this call may be recorded and I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to...
